🔎 Trials Near Me

Dachaigh › Liomfoma Neo-Hodgkin › Tennessee › Nashville

Sgrùdaidhean clionaigeach Liomfoma Neo-Hodgkin ann an Nashville, TN

Tha 21 sgrùdaidhean airson Liomfoma Neo-Hodgkin a’ lorg phàirtichean aig làraichean ann agus timcheall air Nashville (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

A’ fastadhÌre 1/2
  • Tennessee Oncology, Pllc Nashville, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT05006716

Intrathecal Cytarabine and Hydrocortisone for the Early Treatment of ICANS in Patients Undergoing CAR T Therapy for Non Hodgkin Lymphoma

A’ fastadhÌre 2
  • Vanderbilt University/Ingram Cancer Center, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT07763210

A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)

A’ fastadhÌre 1/2
  • SCRI Oncology Partners ( Site 0100), Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07519772

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

A’ fastadhÌre 2
  • Tennessee Oncology - Nashville / Sarah Cannon Research Institute, Nashville
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT02693535

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

A’ fastadhÌre 1
  • SCRI Oncology Partners, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07101328

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

A’ fastadhÌre 1
  • Sarah Cannon Research Institute, Nashville
  • Vanderbilt University Medical Center, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07226843

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

A’ fastadhÌre 1
  • Scri Oncology Partners, Nashville
  • Vanderbilt Medical Center, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT07195916

Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

A’ fastadhÌre 2
  • Research Site, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 11 Sult 2026 · NCT06526793

Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL

A’ fastadhÌre 2
  • Tennessee Oncology, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 11 Sult 2026 · NCT06806033

TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas

A’ fastadhÌre 1
  • SCRI Oncology Partners, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Sult 2026 · NCT07082803

A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

A’ fastadhÌre 1/2
  • Research Site, Franklin · 17 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Lùna 2026 · NCT07123454

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

A’ fastadhÌre 1/2
  • Vanderbilt University Medical Center, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT05826535

A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

A’ fastadhÌre 3
  • Sarah Cannon Research Institute SCRI, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Lùna 2026 · NCT05254743

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

A’ fastadhÌre 1/2
  • TriStar BMT, Nashville
Aoisean 13 gu 90 · Gach gnè · Air ùrachadh 6 Lùna 2026 · NCT06533579

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

A’ fastadhÌre 3
  • SCRI Oncology Partners, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Lùna 2026 · NCT07188558

DALY II USA/ MB-CART2019.1 for DLBCL

A’ fastadhÌre 2
  • SCRI Oncology Partners, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 13 Iuch 2026 · NCT04792489

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

A’ fastadhSgrùdadh amharc
  • Vanderbilt University, Nashville
Gach aois · Gach gnè · Air ùrachadh 6 Iuch 2026 · NCT01351545

A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib

A’ fastadhÌre 4
  • Tennessee Oncology, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Màrt 2026 · NCT06876649

A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

A’ fastadhÌre 4
  • Tennessee Oncology, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Màrt 2026 · NCT06876662

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

A’ fastadhSgrùdadh amharc
  • Massive Bio SYNERGY-AI site, Nashville
Gach aois · Gach gnè · Air ùrachadh 28 Dàmh 2025 · NCT03452774

IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers

A’ fastadhÌre 1/2
  • SCRI Oncology Partners, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 3 Ògmh 2025 · NCT06119685

Sgrùdaidhean Liomfoma Neo-Hodgkin ann am bailtean eile

Sgrùdaidhean eile ann an Nashville

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.